Skip to main content
ROIV
NASDAQ Life Sciences

Roivant Posts $31M Q2 Revenue, Loss Narrower Than Street Expected

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$40.39
Mkt Cap
$28.084B
52W Low
$19.79
52W High
$42.5
52W Position info
104% above low
Off High info
5.0% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

ROIV has more than doubled off its 52-week low of $19.79.

Summary

Roivant reported Q2 revenue of $35.1 million and a net loss of $137.211 million, or -$0.27 per basic share. The operating loss of $268.049 million came in well below the IBES estimate of -$336.3 million, a roughly $68 million favorable gap, with operating expenses at $303.17 million, and the lower than expected operating loss was driven by lower R&D expenses. The quarter follows the August FDA approval and commercial launch of Lisraya for dermatomyositis and positive Phase 3 CLARITY results for brepocitinib in October, so the top line is the first read on early Lisraya uptake. The company entered the quarter with a large liquidity cushion from the prior $950 million Moderna settlement, so the loss is not a funding concern.

At the time of this announcement, ROIV was trading at $40.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.1B. The 52-week trading range was $19.79 to $42.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ROIV - Latest Insights

ROIV
Nov 09, 2026, 7:17 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.00
Real-time Price: $41.00 info
Change: $0 (0%) info
Market Cap: $28.084B info
ROIV
Oct 21, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $36.20
Real-time Price: $41.00 info
Change: +$4.80 (+13%) info
Market Cap: $28.084B info
ROIV
Oct 21, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $36.60
Real-time Price: $41.00 info
Change: +$4.40 (+12%) info
Market Cap: $28.084B info
ROIV
Sep 23, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $37.74
Real-time Price: $41.00 info
Change: +$3.26 (+9%) info
Market Cap: $28.084B info
ROIV
Sep 14, 2026, 7:22 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $40.95
Real-time Price: $41.00 info
Change: +$0.050 (+0.12%) info
Market Cap: $28.084B info